Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aliada Therapeutics

Request full access

Developing drugs for the treatment of diseases of the central nervous system (cns)

Boston, United StatesFounded 2021Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Aliada Therapeutics and the history behind them.

About Aliada Therapeutics

Aliada Therapeutics is a biotechnology company focused on developing innovative therapeutics that advance the delivery of large molecules across the blood-brain barrier. The company's lead program, ALIA 1758, is a differentiated bispecific antibody targeting pyroglutamate amyloid beta and TfR, aimed at effectively clearing amyloid beta plaques from the brain. This approach offers improved convenience and efficacy compared to current treatments. Aliada Therapeutics serves clients in the pharmaceutical and healthcare sectors, particularly those involved in neurology and neurodegenerative diseases. Operating in the biotechnology market, the company employs a business model centered on research and development, clinical trials, and eventual commercialization of its therapeutic solutions. Revenue is generated through partnerships, licensing agreements, and potentially direct sales of approved therapies.

Source: Dealroom company data

At a glance

Founded
2021
Headquarters
Boston, United States
Sector
Biotech & Life Sciences
Outcome tier
Unicorn$1–10B valuation tier

Knowledge graph

Founder mafias, market maps, lists and research connected to this company by Dealroom
Market maps in Biotech & Life Sciences
Market map Rare Disease Therapeutics & Technologies Landscape Market map Digital therapeutics Market map Psychedelic therapeutics
Unicorn lists
Biotech & Life Sciences unicorns Unicorn list Biotech & Life Sciences unicorns Unicorns in United States Unicorn list Unicorns in United States

Open roles

Track hiring at Aliada TherapeuticsOpen roles, team growth and hiring by functionBook a demo
Looking for a job? The startup jobs board lists open roles.Startups hiring now →

Aliada Therapeutics in the Boston ecosystem

Live from Dealroom

The Aliada Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Talent

Book a demo to see the people
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Boston HQ
Book a demo for the full country breakdown
Web traffic by country
110 monthly visits
across markets
🇺🇸 United States90.9%
Top 1 markets shown

Patents

Estimated portfolio value
$229k

2 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aliada Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aliada Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles